Screener
Kairos Pharma KAPA Q1 2026 Annual earnings
Reported May 13, 2026 · Before market open
EPS-$0.08Miss by $0.01
EPS estimate-$0.07
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.09
Versus estimates
Diluted EPS
FAQ
- When did Kairos Pharma report Q1 2026 earnings?
- Kairos Pharma (KAPA) reported Q1 2026 earnings on May 13, 2026 before market open.
- What were Kairos Pharma's Q1 2026 revenue and EPS?
- Kairos Pharma reported eps of $-0.08 for Q1 2026.
- Did Kairos Pharma beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.07 by $0.01.
- How did Kairos Pharma's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 0.0% from $-0.08.
- Where can I find Kairos Pharma's Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001493152-26-014159) directly on SEC EDGAR. The filing index links above go to sec.gov.
